Here’s the thing about this weird hodgepodge of companies: it’s a perfect snapshot of who’s cashing out and who’s crashing out in 2026.

Take Masimo (MASI.US). The patient-monitoring tech company finally found its exit door in May 2026, when its shareholders approved a USD 9.9 billion cash buyout from Danaher. Honestly, taking the cash deal and letting someone else deal with the future of wearable health tech is the smart play here. It’s the same story over at Vocera Communications (VCRB.US), which was scooped up by Stryker. In healthcare tech right now, if you aren’t getting acquired, what are you even doing?

Then we have the pivot plays. EchoStar (ECHO.US) changed its ticker and is trying to rebrand itself from a legacy satellite TV provider into some sort of telecom holding company. Sure, they posted an eye-popping USD 8.46 billion net income in Q2 2026, but let’s be real—that was mostly a non-cash gain. Wall Street is salivating over their SpaceX stake, but the core business is still shedding traditional subscribers. Meanwhile, the private equity giants keep humming along. The Carlyle Group (CG.US) is sitting on a cool USD 485 billion in AUM as of mid-2026. They’re printing fee-related earnings and passing out dividends like candy.

In the real economy, CVR Partners (UAN.US) is proving that sometimes old-school dirt is better than software. Thanks to geopolitical chaos squeezing global fertilizer supplies, their ammonia prices surged in Q2 2026, letting them hand out a hefty USD 6.08 per unit cash distribution. But not every hardware play gets a happy ending. Just look at Fly-E Group (FLYE.US). This electric scooter and bike company is straight-up fighting for its life. In their fiscal Q1 2027 report released in September 2026, they admitted to "substantial doubt" about their ability to survive, with cash reserves dwindling to roughly USD 60,000. It’s a harsh reminder that making hardware is brutally hard, and not everyone gets a soft landing.